Liminatus Pharma, Inc. - 10-Q Filing
Liminatus Pharma filed a Form 10-Q for the quarter ending March 31, 2026. The filing includes financial data and disclosures related to various loans with related parties such as Valetudo, Prophase, Hana, Ewon, Amantes, and others from June 2023 through April 2025. It also references a best efforts public offering on February 18, 2026, involving common stock and pre-funded warrants.
Tickers: $LIMN